Ambience Healthcare Announces $243 Million Series C to Scale its AI Platform for Health Systems

July 29, 2025 9:05 AM

Ambience Healthcare, the leading ambient AI platform for documentation, coding, and clinical documentation integrity (CDI), today announced a $243 million Series C round to scale its AI platform for health systems. The round was co-led by Oak HC/FT and Andreessen Horowitz (a16z), with participation from existing investors including the OpenAI Startup Fund, Kleiner Perkins, and Optum Ventures. New investors in the round include Frist Cressey...

Read more

Alter Behavioral Health Nominated for Best Behavioral Health Facility in Southern California

July 29, 2025 9:00 AM

Alter Behavioral Health has been nominated for Best Behavioral Health Facility in Southern California by the Santa Monica Daily Press. The nomination highlights the program's residential mental health services for adults dealing with conditions such as depression, anxiety, PTSD, and dissociative disorders.Alter operates two full-time mental health facilities in Orange County. Care is provided 24 hours a day, seven days a week. Clients live...

Read more

Omaha-Based Fusion Improves the Lives of Everyone We Touch Through Philanthropic Impact

July 29, 2025 9:00 AM

Omaha-based healthcare company Fusion employees dedicated over 1,740 hours to engaging with the community in the first half of 2025. Employees volunteered at organizations around Omaha for over 580 of those hours, and the rest was spent at awareness events and fundraisers. This service upholds Fusion's mission "to improve the lives of everyone we touch."Some of the supported organizations include QLI, the Stephen Center, MS Forward, and Share...

Read more

Ovation Science Expands with Planet 13 into Florida

July 29, 2025 8:00 AM

Ovation Science Inc. (CSE:OVAT)(OTC:OVATF) ("Ovation" or the "Company"), today announced an expanded license agreement with Planet 13 Holdings, Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13") to bring its patented Invisicare® topical and transdermal cannabis products to the Florida market. The agreement will make Ovation's science-backed topical products available across Planet 13's extensive network of 33 Florida dispensary locations, building on the...

Read more

MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain

July 29, 2025 7:30 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing novel therapies for neurologic, neuropsychiatric, and metabolic disorders, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for Ketamir-2, a novel oral NMDA receptor antagonist for the treatment of neuropathic pain.The IND submission included a comprehensive data package...

Read more

Dr. Linda Anegawa Joins Tonum Health as Chief Medical Advisor

July 29, 2025 7:04 AM

Tonum Health, a developer of science-backed natural supplements for cognitive performance, weight loss, and metabolic health is proud to announce that Linda Anegawa, M.D., FACP, has joined the company as Chief Medical Advisor. Dr. Anegawa brings over 20 years of clinical and leadership experience to Tonum Health. In her new role, she will guide the company's medical strategy across Tonum's expanding product portfolio. Dr. Anegawa will also...

Read more

CHKD Reduces Medical Message Intake Burden by 60% With TriageLogic

July 29, 2025 7:00 AM

In early 2025, a leading pediatric health system in Virginia took a bold step toward modernizing patient access - one that's already reshaping their operations and improving satisfaction across the board. Hampton Roads Pediatrics, part of the Children's Hospital of The King's Daughters (CHKD) Medical Group, had been struggling with call volume and staffing limitations. Within weeks of implementing TriageLogic's MedMessage Automate, over 60% of...

Read more

"Ozempic Makeovers" on the Rise: Dr. Meegan Gruber Addresses Post-Weight-Loss Skin Laxity With Awake Body Contouring

July 29, 2025 7:00 AM

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave patients with loose, sagging skin on the face, arms, abdomen, and thighs. In response, Dr. Meegan Gruber, board-certified plastic surgeon and founder of Gruber Plastic Surgery, is witnessing a dramatic uptick in requests for what social media now...

Read more

CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase

July 29, 2025 7:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), an emerging leader in the cannabinoid and alternative wellness space, is excited to announce that the company is in the final stages of executing a lease agreement for its second brick-and-mortar retail location, marking a major milestone in its aggressive growth strategy. The new store will be housed inside one of Arizona's most prominent high-traffic malls, reflecting the company's continued upward...

Read more

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

July 29, 2025 7:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) today announced a definitive agreement under which Bausch Health will indirectly acquire DURECT Corporation, including a novel therapeutic molecule, larsucosterol, which can harness the power of epigenetic modulation. Larsucosterol, an endogenous sulfated oxysterol and an epigenetic modulator, has demonstrated...

Read more

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

July 29, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2025 ended June 30, 2025, after the market closes on Thursday, August 7, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can also be...

Read more

SleepLean Reviews (INVESTIGATED) We Tried It for 3 Months And Here's What Shocked Us About the Weight Loss & Sleep Results

July 29, 2025 6:00 AM

We weren't expecting much when we started using SleepLean. The claims seemed bold: melt fat while sleeping, balance stress hormones, wake up energized, without changing diet or adding workouts. It sounded like a marketing gimmick. But after 90 days of nightly use, we can say this with confidence: Sleeplean Is Not Just Hype. It Changed Everything (Verified Source). In this 2025 investigation, we take you inside Our Full 3-Month Journey Testing...

Read more

Is DEA Marijuana Lies Civil Misconduct or Criminal Fraud? DEA Administrator's First Marijuana Decision

July 29, 2025 5:00 AM

The Drug Enforcement Administration just perjured itself in the matter of MMJ BioPharma Cultivation. In a July 25 filing signed by attorney Aarathi D. Haig, the DEA outrageously claimed that MMJ "had no bona fide supply agreement (BFSA)" with a Schedule I registrant. That statement is not only false; it's demonstrably, documentably false. We have the signed, sealed BFSA between MMJ BioPharma and a DEA-registered Schedule I manufacturer. The...

Read more

From Battlefield to Boardroom: Dr. Sudip Bose Emerges as a Global Voice in Crisis Leadership and Medical Innovation

July 29, 2025 3:20 AM

What do Fortune 500 CEOs, military commanders, and ER physicians have in common? They turn to Dr. Sudip Bose when lives-or companies-are on the line. From battlefield triage in combat zones to transforming rural healthcare systems, Dr. Bose is becoming one of the world's most trusted voices in crisis leadership and innovation. As a decorated U.S. Army combat veteran, emergency physician, and executive producer of the Amazon Prime series Desert...

Read more

Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing

July 29, 2025 3:00 AM

LONDON, UK / ACCESS Newswire / July 29, 2025 /IntroductionHemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised gross proceeds of £250,000 via an allotment to Vladislav Sandler of 133,690 new ordinary shares of £0.01 each ("New Ordinary Shares") at an issue price of 187p, representing a premium to the present market price (the "Issue Price").The net proceeds of this fundraise will be dedicated to the continuation of...

Read more

New Scientific Article Published on Positive Clinical Results with Painless ACD440 Against Neuropathic Pain

July 29, 2025 2:20 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that a scientific article has been published on the clinical phase IIa results supporting the continued development of the lead drug candidate Painless ACD440.The article, titled Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces...

Read more

Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze

July 29, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) ("Relief" or the "Company"), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the execution of a binding term sheet for a proposed business combination with NeuroX Group SA ("NeuroX"), a privately held company that recently acquired the assets and operations of MindMaze - a recognized...

Read more

Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation

July 28, 2025 4:30 PM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have received CE approval. At the same time XVIVO estimates delays of approximately 6-12 months for the CE approval of XVIVO's heart perfusion solution and supplement, which are part of its´ innovative heart preservation technology. The delay is due to the consultation process at an EU competent authority.XVIVO...

Read more

Neuro Surge For Brain Fog & Focus: EXPOSING Fake Reviews, Cognitive Health Claims, Hidden Complaints & Where To Buy The Real Supplement in 2025

July 28, 2025 12:05 PM

In 2025, the war on brain fog isn't slowing down. Mental burnout, poor focus, and cognitive fatigue are hitting younger and older adults alike, fueled by stress, overuse of screens, and neurological strain. Enter Neuro Surge, a nootropic-style supplement making bold promises: improved memory, clearer thinking, reduced anxiety, and even better blood flow to the brain. But behind the surge in online hype are thousands of unanswered questions. Are...

Read more

Medical Component Specialists Announces NVBDC Veteran-Owned Business Certification

July 28, 2025 11:45 AM

Medical Component Specialists is proud to announce that the company has recently been recognized by the National Veteran Business Development Council (NVBDC) as a Veteran-Owned Business (VOB). Since 2017, the NVBDC has been the accepted Service Disabled/VOB certification body of the Billion Dollar Roundtable, an organization whose members consist exclusively of U.S.-based corporations that have attained $1 billion or more in annual Tier 1...

Read more